Drug Trial Radar · NCT06872866
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Apr 15, 2025
Primary completion
Feb 28, 2026
Study completion Feb 28, 2026
Sponsor
- Lead sponsor
- Aspargo Labs, IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 20 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects
Conditions
- Erectile Dysfunction
Interventions
ASP-001.1Drug
Oral liquid suspension of sildenafil
ASP-001.1Device
Bottle/pump containing ASP-001.1 suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- CmaxTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
- AUCtTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
- TmaxTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
- ThalfTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
- KelTime frame: Baseline and at 26 different timepoints during the 24 hour post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aspargo Labs
New York, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.